| 1 |
Arbyn M, Castellsagué X, de Sanjosé S, et al. Worldwide burden of cervical cancer in 2008[J]. Ann Oncol, 2011, 22(12):2675-2686.
|
| 2 |
Saxena U, Sauvaget C, Sankaranarayanan R. Evidence-based screening, early diagnosis and treatment strategy of cervical cancer for national policy in low-resource countries: example of India[J]. Asian Pac J Cancer Prev, 2012, 13(4):1699-1703.
|
| 3 |
Choi YH, Chapman R, Gay N, et al. Potential overestimation of HPV vaccine impact due to unmasking of non-vaccine types: quantification using a multi-type mathematical model[J]. Vaccine, 2012, 30(23):3383-3388.
|
| 4 |
Harper DM, Demars LR. Primary strategies for HPV infection and cervical cancer prevention[J]. Clin Obstet-Gynecol, 2014, 57(2):256-278.
|
| 5 |
Saslow D, Solomon D, Lawson HW, et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer[J]. CA Cancer J Clin, 2012, 62(3):147-172.
|
| 6 |
Arbyn M, Bergeron C, Klinkhamer P, et al. Liquid compared with conventional cervical cytology: a systematic review and meta-analysis[J]. Obstet Gynecol, 2008, 111(1):167-177.
|
| 7 |
Rijkaart DC, Berkhof J, van Kemenade FJ, et al. HPV DNA testing in population based cervical screening (VUSA-Screen study): results and implications[J]. Br J Cancer, 2012, 106(5):975-981.
|
| 8 |
Moyer VA. Screening for cervical cancer: US Preventive Services Task Force recommendation statement[J]. Ann Intern Med, 2012, 156(12):880-891, W312.
|
| 9 |
Sahasrabuddhe VV, Bhosale RA, Kavatkar AN, et al. Comparison of visual inspection with acetic acid and cervical cytology to detect high-grade cervical neoplasia among HIV-infected women in India[J]. Int J Cancer, 2012, 130(1):234-240.
|
| 10 |
Saslow D, Solomon D, Lawson HW, et al, American Cancer Society, American Society for Colposcopy and Cervical Pathology, American Society for Clinical Patholog. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer[J]. Am J Clin Pathol, 2012, 137(4):516-542.
|
| 11 |
Committee on Practice Bulletins-Gynecology. ACOG practice bulletin number 131: screening for cervical cancer[J]. Obstet Gynecol 2012, 120(5):1222-1238.
|
| 12 |
Smith RA, Cokkinides V, Brooks D, et al. Cancer screening in the United States, 2010: a review of current American Cancer Society guidelines and issues in cancer screening[J]. CA Cancer J Clin, 2010, 60(2):99-119.
|
| 13 |
Vijayaraghavan A, Efrusy MB, Mayrand MH, et al. Cost-effectiveness of high-risk human papillomavirus testing for cervical cancer screening in Québec, Canada[J]. Can J Public Health, 2010, 101(3):220-225.
|
| 14 |
Volerman A, Cifu AS. Cervical cancer screening[J]. JAMA, 2014, 312(21):2279-2280.
|